Cooper Companies Inc (COO) Peer Comparison
$53.91
As on 11-Sep-2026 16:17EDT
Market cap
$10,251 Mln
Revenue (TTM)
$4,237 Mln
P/E Ratio
18.5
P/B Ratio
1.2
Div. Yield
0 %
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
10,251 | 117,195 | 42,255 | 41,429 | 85 |
Revenue ($ Mln) |
4,237 | 37,542 | 3,458 | 7,372 | 2 |
Net Profit ($ Mln) |
570.30 | 5,230.00 | 1,014.77 | 1,440.00 | -6.96 |
Net Margin (%) |
13.46 | 13.93 | 29.34 | 19.53 | -430.43 |
RoE (%) |
6.83 | 10.47 | 13.86 | 20.18 | -115.97 |
Price to Earnings |
18.53 | 22.62 | 42.71 | 28.26 | -- |
Price-To-Book |
1.23 | 2.34 | 5.68 | 5.48 | 15.80 |
Income Statement ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
4,092.40 | 33,537.00 | 2,746.62 | 6,948.00 | 2.14 |
|
Cost of Revenue
|
1,609.50 | 11,632.00 | 699.64 | 3,305.00 | 1.44 |
|
Gross Profit
|
2,482.90 | 21,905.00 | 2,046.98 | 3,643.00 | 0.70 |
|
Operating Expenses
|
1,800.00 | 15,950.00 | 1,355.55 | 2,164.00 | 7.39 |
|
Operating Profit (EBIT)
|
682.90 | 5,955.00 | 691.44 | 1,479.00 | -6.69 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
566.50 | 5,628.00 | 919.38 | 1,435.00 | -10.48 |
|
Provision for Tax
|
191.60 | 936.00 | 205.24 | 132.00 | 0.00 |
|
Profit after Tax (Net Income)
|
374.90 | 4,662.00 | 714.14 | 1,303.00 | -10.48 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 4,662.00 | -- | 1,303.00 | -- |
Liabilities ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
8,238.90 | 48,024.00 | 5,832.37 | 6,741.00 | 6.43 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
3,042.90 | 30,545.00 | 108.98 | 3,639.00 | 0.06 |
|
Current Liabilities
|
1,112.80 | 12,879.00 | 1,398.40 | 2,347.00 | 0.98 |
|
Total Liabilities
|
12,394.80 | 91,680.00 | 7,339.76 | 12,727.00 | 7.47 |
Assets ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
10,288.40 | 67,865.00 | 1,030.95 | 8,133.00 | 2.68 |
|
Current Assets
|
2,106.40 | 23,814.00 | 6,308.80 | 4,594.00 | 4.79 |
|
Total Assets
|
12,394.80 | 91,680.00 | 7,339.76 | 12,727.00 | 7.47 |
|
Total Debt*
|
2,783.60 | 28,516.00 | 75.78 | 3,354.00 | 0.19 |
|
Net Current Assets
|
993.60 | 10,935.00 | 4,910.40 | 2,247.00 | 3.81 |
Cashflow ($ Mln)
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
796.10 | 7,044.00 | 1,090.05 | 1,559.00 | -4.63 |
|
Cash Flow from Investing Activities
|
-372.90 | -1,937.00 | -700.14 | -394.00 | -0.09 |
|
Cash from Financing Activities
|
-425.90 | -4,361.00 | 26.12 | -715.00 | 8.54 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
3.46 | 6.14 | 13.46 | 13.32 | -157.70 |
|
ROE (%)
|
4.59 | 9.49 | 13.63 | 20.62 | -162.94 |
|
ROA (%)
|
3.03 | 5.13 | 10.78 | 10.61 | -139.89 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
9.16 | 13.90 | 26.00 | 18.75 | -489.86 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.05 | 0.04 | 0.16 | 0.07 | 0.03 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-4.44 | 26.82 | 35.84 | 1.09 | -91.11 |
|
EPS Growth (%)
|
-- | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | -- |
|
Price / Book Value
|
-- | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
2.54 | 2.12 | -5.29 | 0.85 | 0.41 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.34 | 0.59 | 0.01 | 0.50 | 0.03 |
|
Short term debt to equity ratio
|
0.01 | 0.06 | 0.00 | 0.05 | 0.02 |
|
Current Ratio
|
1.89 | 1.85 | 4.51 | 1.96 | 4.88 |
|
Quick Ratio
|
1.13 | 1.42 | -- | 1.52 | 4.66 |
|
Interest Coverage
|
6.30 | 8.72 | -- | 13.81 | -488.67 |
Operating Efficiency Ratios
| Cooper Companies Inc (COO) | Medtronic PLC (MDT) | Veeva Systems Inc. Class A (VEEV) | Agilent Technologies (A) | Nutriband Inc (NTRB) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.26 | 19.43 | 38.49 | 21.40 | 3.45 |
|
Asset Turnover
|
0.33 | 0.37 | 0.41 | 0.57 | 0.29 |
|
Receivable days
|
68.99 | 68.85 | 129.37 | 73.89 | 18.99 |
|
Inventory Days
|
187.07 | 167.88 | 0.00 | 111.40 | 48.27 |
|
Payable days
|
63.64 | 76.29 | 16.17 | 61.34 | 174.88 |
|
Cash Conversion Cycle
|
192.42 | 160.44 | 109.59 | 123.95 | -107.62 |